Acute Myeloid Leukaemia
1. Epidemiology & Aetiology
2. Pathogenesis
3. Classification
4. Clinical features
5. Laboratory Investigation
6. Prognostic factors and Treatment

Acute Lymphoblastic Leukemia
1. Epidemiology & Aetiology
2. Pathogenesis
3. Clinical features
4. Laboratory Investigation
5. Treatment

Chronic Lymphocytic Leukemia
1. Epidemiology & Aetiology
2. Pathogenesis
3. Clinical features
4. Laboratory Investigation
5. Treatment

Chronic Myeloid Leukemia
1. Epidemiology & Aetiology
2. Pathogenesis
3. Clinical features
4. Laboratory Investigation
5. Treatment

Plasma Cell Myeloma
1. Epidemiology & Aetiology
2. Pathogenesis
3. Clinical features
4. Laboratory Investigation
5. Treatment

Q1 : What is the difference between acute and chronic leukaemia?
A1 : Acute leukaemia is characterized by undifferentiated or immature cells, usually a blast cell, and the onset of disease is abrupt and rapid with a short survival time. In chronic leukaemia the predominant cell is more differentiated or mature but does not function normally, with a relatively slow progression.

Q2 : What is hyperviscosity syndrome?
A2 : Hyperviscosity syndrome is a condition in which blood isn't able to flow freely through your arteries. In this syndrome, arterial blockages can happen due to too many red blood cells, white blood cells, or proteins in your bloodstream.

Q3 : What is paraproteinaemia?
A3 : Paraproteinemia is a finding of a high concentration of monoclonal immunoglobulin or immunoglobulin fragment, so-called paraprotein or serum M component (M for monoclonal) produced in any one of a diverse group of immunoproliferative disorders involving the proliferation of a single clone of cells.